KYNEXIS
LIVE

Serial Number

79374076

Owner

KyNexis B.V.

Attorney

R. Glenn Schroeder

Filing Date

Jun 6, 2023

Add to watchlist:

No watchlists yet
View on USPTO

KYNEXIS Trademark

Serial Number: 79374076 • Registration: 7490732

KYNEXIS is a trademark filed by KyNexis B.V. on June 6, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

KyNexis B.V.

Gooimeer 2-35

Entity Type: 26

Trademark Details

Filing Date

June 6, 2023

Registration Date

September 3, 2024

Published for Opposition

June 18, 2024

Goods & Services

Pharmaceutical products, namely, small molecules, biologics and gene therapies, for the treatment of central nervous system diseases and disorders; biological preparations for use in medical and clinical gene therapy; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnostic and gene testing; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, and other pharmaceuticals for the prevention of onset and worsening of central nervous system diseases and disorders

Fundamental product and medical research, product development and consultancy in the field of biotechnology, namely, biomedical research and product development, medical science, chemistry and biochemistry; research and product development in the field of pharmaceuticals

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 8, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 19, 2025 FICS
FINAL DISPOSITION PROCESSED
Feb 18, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 4, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 16, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 13, 2024 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 4, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 3, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 3, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Jul 20, 2024 GPNX
NOTIFICATION PROCESSED BY IB
Jul 1, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 18, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 18, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 14, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 13, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 12, 2024 OP2R
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jun 5, 2024 LIMN
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 29, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 15, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
May 15, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 15, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
May 15, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 15, 2024 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
May 2, 2024 GNFN
FINAL REFUSAL E-MAILED
May 2, 2024 GNFR
FINAL REFUSAL WRITTEN
May 2, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 1, 2024 TROA
REFUSAL PROCESSED BY IB
Apr 8, 2024 RFNT
LIMITATION OF GOODS RECEIVED FROM IB
Apr 6, 2024 LIMG
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 20, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 20, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 1, 2024 RFCR
NON-FINAL ACTION WRITTEN
Feb 29, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 27, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 18, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 14, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 13, 2023 REPR